“What’s for dinner? It’s a deceptively simple question, asked millions of times each day. But consider the myriad factors that go into answering it—from cost to convenience to climate change—and it’s no wonder we spend so much time thinking about the food we eat.”
Best Diet Plans for People with Diabetes, Reviewed by Experts
“We had experts weigh in on the best diets for people with diabetes. Read our summary of the top research-backed diets that can benefit your blood sugar and more.”
Mindfulness Improves Sleep and Reduces Stress
“Summary: A new study reveals that mindfulness helps improve sleep quality and reduce stress by focusing on the present and minimizing negative thoughts. The study tracked 144 nurses over two weeks, highlighting how mindfulness influences emotion regulation and overall well-being.”
Large-scale study assesses the short-term impact on stress of self-administered mindfulness exercises
“Mindfulness practices, derived from ancient meditative traditions, have become increasingly popular in modern society. Past studies have found that these practices, which encourage people to intentionally direct their attention to the present moment, can have a multitude of benefits, such as reducing stress, aiding emotional regulation and improving concentration.”
Gut-Skin Axis: How the Magical Powers of the Gut Microbiome Extend to Skin Health
“Our “gut health” remains one of the hottest topics under the wide umbrella that is all things wellness, and for good reason: Your gut microbiome, and all the “good” and “bad” bacteria living in it, is like its own little city or ecosystem. How well it functions has been linked to many other measures of your overall health, including immunity, mental health, our environment, medication history and more.”
Wegovy, Ozempic Are Overpriced By 400-500%: Here’s A Quick Solution
“A whopping 1 in 8 U.S. adults have taken GLP-1 drugs like Wegovy and Ozempic for weight loss and related conditions. Their popularity and efficacy have sparked a prescription-writing frenzy in recent years, leaving both medications on the FDA’s drug shortage list since May 2023.”
FDA Commissioner Says ‘We’re Failing’ People With Type 2 Diabetes
“Key takeaways – In the keynote address at the American Diabetes Association annual conference, FDA Commissioner Dr. Robert Califf expressed concerns about the rising rates of diabetes in the U.S. Though revolutionary medications and technologies for diabetes and weight loss continue to emerge, these treatments are vastly underused. The silver lining lies with type 1 diabetes therapies, which are showing great promise in clinical trials.”
